Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00489359

Femme Homme

Extrait

The purpose of this study is to determine efficacy of the combination therapy of pemetrexed and carboplatin as treatment for patients with platinum-sensitive ovarian cancer. This study also includes patients with primary peritoneal cancer.


Critère d'inclusion

  • Ovarian Cancer ,Primary Peritoneal Cancer


Liens